The Pennant Group, Inc.
NASDAQ:PNTG · NASDAQ Global Select
-$0.83 today
Vol 0.34M · Avg 0.25M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Stock Ticker Earnings Waterfall
NASDAQ:PNTG · Revenue to Net Income
Key Ratios
Analysis
$1.0B of revenue converted into $30.3M of net income for the selected period. Gross margin is 15.0% and net margin is 3.0%, showing how much revenue survives after costs and taxes. EPS is $0.85, tying the income statement back to per-share earnings.
Income Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $947.7M +36.3% | $695.2M +27.6% | $544.9M +15.1% | $473.2M +7.6% | $439.7M | $809.6M | $921.6M | $731.2M |
| Cost of Revenue | $825.2M +37.2% | $601.5M +25.9% | $477.9M +15.2% | $414.7M +6.0% | $391.1M | $725.6M | $804.0M | $882.4M |
| Gross Profit | $122.5M +30.6% | $93.8M +39.9% | $67.0M +14.4% | $58.6M +20.6% | $48.6M | $8.9B | $7.6B | $6.2B |
| Gross Margin | 12.9% -0.6pp | 13.5% +1.2pp | 12.3% -0.1pp | 12.4% +1.3pp | 11.1% | 9.8% | 28.9% | 38.3% |
| Research & Development | $0 | $0 | $0 | $0 | $0 | $983.2M | $1.3B | $490.4M |
| Selling, General & Admin | $71.1M +41.6% | $50.2M +36.9% | $36.7M +7.9% | $34.0M -6.3% | $36.3M | $620.6M | $923.0M | -$1.5B |
| Operating Expenses | $71.1M +27.7% | $55.6M +32.9% | $41.9M -8.7% | $45.8M +4.4% | $43.9M | $5.3B | $7.0B | $8.7B |
| Depreciation & Amortization | $8.5M +39.5% | $6.1M +19.3% | $5.1M +4.7% | $4.9M +2.4% | $4.8M | $374.2M | $1.2B | $631.8M |
| EBITDA | $60.8M +36.9% | $44.4M +45.1% | $30.6M +74.0% | $17.6M +86.2% | $9.5M | -$15.2B | $6.8B | $9.3B |
| EBITDA Margin | 6.4% +0.0pp | 6.4% +0.8pp | 5.6% +1.9pp | 3.7% +1.6pp | 2.2% | 5.6% | 46.3% | 42.0% |
| Operating Income | $51.4M +34.8% | $38.1M +51.4% | $25.2M +97.6% | $12.7M +171.3% | $4.7M | $12.3B | $14.0B | -$15.7B |
| Operating Margin | 5.4% -0.1pp | 5.5% +0.9pp | 4.6% +1.9pp | 2.7% +1.6pp | 1.1% | 16.6% | 24.1% | 22.0% |
| Interest Income | $0 | $0 | $0 | $0 | $0 | -$1.5B | -$1.6B | $405.0M |
| Interest Expense | $6.7M -4.0% | $7.0M +17.4% | $5.9M +55.2% | $3.8M +96.6% | $1.9M | $1.1B | $1.0B | $1.2B |
| Other Income / Expenses | -$5.8M +14.7% | -$6.7M -20.8% | -$5.6M -45.2% | -$3.8M -95.8% | -$2.0M | -$1.5B | $1.4B | $1.2B |
| Income Before Tax | $45.6M +45.5% | $31.4M +60.2% | $19.6M +120.2% | $8.9M +225.7% | $2.7M | $3.3B | $4.9B | $3.6B |
| Pre-Tax Margin | 4.8% +0.3pp | 4.5% +0.9pp | 3.6% +1.7pp | 1.9% +1.3pp | 0.6% | 20.8% | 18.7% | 26.2% |
| Income Tax Expense | $11.9M +68.8% | $7.0M +23.9% | $5.7M +244.1% | $1.6M +183.3% | $582.0K | $1.3B | -$1.6B | $745.2M |
| Net Income | $29.6M +31.1% | $22.6M +68.6% | $13.4M +101.4% | $6.6M +146.4% | $2.7M | $4.9B | $4.8B | $4.7B |
| Net Margin | 3.1% -0.1pp | 3.2% +0.8pp | 2.5% +1.1pp | 1.4% +0.8pp | 0.6% | 12.4% | 17.5% | 22.5% |
| EPS (Basic) | $1 +19.4% | $1 +60.0% | $0 +95.7% | $0 +204.2% | $0 | $400.8M | $703.2M | $1.3B |
| EPS (Diluted) | $1 +18.3% | $1 +61.4% | $0 +100.0% | $0 +213.8% | $0 | $766.2M | $609.4M | $452.6M |
| Weighted Avg Shares | $34.6M +10.8% | $31.2M +4.4% | $29.9M +2.7% | $29.1M +2.3% | $28.4M | $757.8M | $925.8M | $1.1B |
| Weighted Avg Shares (Diluted) | $35.3M +10.4% | $32.0M +6.0% | $30.2M +0.1% | $30.2M -1.6% | $30.6M | $1.2B | $924.4M | $678.0M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Integra LifeSciences Holdings Corporation
NASDAQ:IART
$1.39B
Bicara Therapeutics Inc. Common Stock
NASDAQ:BCAX
$1.25B
InnovAge Holding Corp.
NASDAQ:INNV
$1.24B
AMN Healthcare Services, Inc.
NYSE:AMN
$1.21B
EyePoint Pharmaceuticals, Inc.
NASDAQ:EYPT
$1.12B
Kura Oncology, Inc.
NASDAQ:KURA
$852.68M
HealthStream, Inc.
NASDAQ:HSTM
$747.22M
Sonida Senior Living, Inc.
NYSE:SNDA
$697.66M
CorMedix Inc.
NASDAQ:CRMD
$686.06M
ProKidney Corp.
NASDAQ:PROK
$261.51M
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does PNTG generate?
The Pennant Group, Inc. (PNTG) reported $947.71M of revenue in fiscal 2025.
Is PNTG profitable?
The Pennant Group, Inc. (PNTG) reported $29.58M of net income, with a net margin of 3.1%.
Explore More
Continue the stock analysis
Jump to another research area for this company.